Benefits of SGLT2 inhibitors in arrhythmias

Some studies have shown that sodium-glucose cotransporter (SGLT) 2 inhibitors can definitively attenuate the occurrence of cardiovascular diseases such as heart failure (HF), dilated cardiomyopathy (DCM), and myocardial infarction. With the development of research, SGLT2 inhibitors can also reduce t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jinghan, Xue, Genlong, Zhan, Ge, Wang, Xinying, Li, Jiatian, Yang, Xiaolei, Xia, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631490/
https://www.ncbi.nlm.nih.gov/pubmed/36337862
http://dx.doi.org/10.3389/fcvm.2022.1011429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631490/
https://www.ncbi.nlm.nih.gov/pubmed/36337862
http://dx.doi.org/10.3389/fcvm.2022.1011429

Ejemplares similares